Pycnogenol® Improves Microcirculation, Retinal Edema, and Visual Acuity in Early Diabetic Retinopathy

Steigerwalt, Robert; Belcaro, Gianni; Cesarone, Maria Rosaria; Di Renzo, Andrea; Grossi, Maria Giovanna; Ricci, Andrea; Dugall, Mark; Cacchio, Marisa; Schönlau, Frank
December 2009
Journal of Ocular Pharmacology & Therapeutics;Dec2009, Vol. 25 Issue 6, p537
Academic Journal
Purpose: The growing numbers of diabetes cases in the developed world are followed by increasing numbers of people diagnosed with diabetic complications. Diabetic microangiopathies in the eye lead to the development of retinopathy involving gradual loss of vision. Previous studies with Pycnogenol® showed effectiveness for stopping progression of preproliferative stages of retinopathy. The aim of our study was to show protective effects of Pycnogenol in early stages of retinopathy, characterized by mild to moderate retinal edema in the absence of hemorrhages or hard exudates in the macula center. Methods: Following treatment with Pycnogenol (24 patients) for 3 months, retinal edema score (dilated ophthalmology) and retinal thickness (high resolution ultrasound) showed statistically significant improvement as compared to the placebo group (22 patients), which showed negligible changes to baseline. Laser Doppler flow velocity measurements at the central retinal artery showed a statistically significant increase from 34 to 44 cm/s in the Pycnogenol group as compared to marginal effects in the control group. Results: The major positive observation of this study is the visual improvement, which was subjectively perceived by 18 out of 24 patients in the Pycnogenol group. Testing of visual acuity using the Snellen chart showed a significant improvement from baseline 14/20 to 17/20 already, after 2 months treatment, whereas no change was found in the control group. Conclusions: Pycnogenol taken at this early stage of retinopathy may enhance retinal blood circulation accompanied by regression of edema, which favorably improves vision of patients.


Related Articles

  • Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice. Vedantham, Vasumathy; Kim, Ramasamy // Indian Journal of Ophthalmology;Jun2006, Vol. 54 Issue 2, p133 

    Diabetic retinopathy is fast emerging as a leading cause of newly diagnosed legal blindness amongst the working population. Macular edema, as it is commoner, accounts for more vision impairment than neovascular proliferation in diabetic patients. Laser photocoagulation, which is the standard...

  • Visual Fields Refine Understanding of Diabetic Retinopathy Progression. Jackson, Gregory R.; Gardner, Thomas W. // Diabetes;Sep2014, Vol. 63 Issue 9, p2909 

    The article focuses on a study which examined the effect of diabetes on the neural retina. Topics discussed include the finding that deterioration of the neural retina may take place for years without a clinically detectable change in the microvasculature, and evidence showing that diabetic...

  • Longitudinal comparison of visual acuity as measured by the ETDRS chart and by the potential acuity meter in eyes with macular edema, and its relationship with retinal thickness and sensitivity. Hatef, E; Hanout, M; Moradi, A; Colantuoni, E; Bittencourt, M; Liu, H; Sepah, Y J; Ibrahim, M; Do, D V; Guyton, D L; Nguyen, Q D // Eye;Oct2014, Vol. 28 Issue 10, p1239 

    PurposeTo evaluate the relationship between visual acuity as measured by the Early Treatment Diabetic Retinopathy Study (ETDRS) chart and by the potential acuity meter (PAM) with retinal thickness and sensitivity measured by a combined microperimetry/optical coherence tomography system...

  • Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes. Hietala, Kustaa; Harjutsalo, Valma; Forsblom, Carol; Summanen, Paula; Groop, Per-Henrik // Diabetes Care;Jun2010, Vol. 33 Issue 6, p1315 

    OBJECTIVE -- Age at onset of type 1 diabetes influences the risk of microvascular complications. However, the long-term risk of proliferative retinopathy within the wide spectrum of age at onset of type 1 diabetes is less well known. RESEARCH DESIGN AND METHODS-- A sample of 1,117 consecutively...

  • Intravitreal bevacizumab (avastin) for proliferative diabetic retinopathy: 6-months follow-up. Arevalo, J. F.; Wu, L.; Sanchez, J. G.; Maia, M.; Saravia, M. J.; Fernandez, C. F.; Evans, T. // Eye;Jan2009, Vol. 23 Issue 1, p117 

    AimsTo study the effects of intravitreal bevacizumab (Avastin) on retinal neovascularization (RN) in patients with proliferative diabetic retinopathy (PDR).MethodsRetrospective study of patients with RN due to PDR who were treated with at least one intravitreal injection of 1.25 or 2.5 mg of...


    Purpose of the paper: Assessment of retinal fluorescein angiography role in the patients with diabetic retinopathy and implicitly, the role of this method in establishing the diagnosis and the optimal therapy for these patients. Methods: Prospective interventional non-comparative study. We...

  • The Influence on Treatment Efficiency in Diabetic Retinopathy by Laser Photocoagulation Area. Ming Zheng; Zhihua Cui; Xiaoying Hu; Mengmeng Zhang; You Zhou; Chunguang Zhou // Journal of Convergence Information Technology;Aug2012, Vol. 7 Issue 14, p269 

    A computer approach for calculating the laser photocoagulation area from diabetic retinopathy laser therapy images had been proposed and used in this paper. This algorithm used canny edge detection method to find the edges and the connectors in the images. The moderate sized non-linear...

  • Intravitreal Bevacizumab for Diabetic Papillopathy. Örnek, Kemal; Oğurel, Tevfik // Journal of Ocular Pharmacology & Therapeutics;Apr2010, Vol. 26 Issue 2, p217 

    A 43-year-old woman presented with a visual acuity of 1/10 in the right eye and 3/10 in the left eye. Ophthalmologic examination disclosed optic disc swelling on both sides with mild nonproliferative diabetic retinopathy. The pupils were equal and reactive without an afferent pupillary defect....

  • YoÄŸun Premaküler Subhyaloid Hemorajide ND:Yag Lazer Hyaloidotomi. Dınç, Umut Aslı; Yenerel, Melda; Görgün, Ebru // Retina-Vitreus/Journal of Retina-Vitreous;Jun2008, Vol. 16 Issue 2, p157 

    We descibe a case of dense premacular subhyaloid hemorrhage in a patient with non-proliferative diabetic retinopathy treated by Neodymium:yttrium-aluminum-garnet (Nd:YAG) laser. Maximum laser power of 8.5 mJ Nd:YAG laser was applicated, and when a small leakage from subhyaloid hemorrhage into...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics